According to a study by Yun et al., mutations in KRAS and BRAF upregulated glucose transporter GLUT-1 and increased glucose uptake in CRC cells, while mitochondrial function and oxidative respiration were not impaired [139]. Here, SLC2A1 is linked to colorectal carcinoma.